ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105132 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105132; 2) Community: the network communities that were significantly associated with the response to NSC 105132; 3) Molecule: the relationships between components within communities and NSC 105132; 4) MDR: the compounds that were significantly associated with the NSC 105132.

NSC Compound Enrichment Correlation
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0375780807984386 0.27810608
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.0375780807984386 -0.086737192
NSC 22070 Chrysanthin 0.0375780807984386 0.12439985
NSC 270057 Hydroxypristimerin 0.0375780807984386 0.16664526
NSC 349174 Oxanthrazole 0.0375780807984386 0.6527764
NSC 622115 Null 0.0375780807984386 -0.092945794
NSC 632840 Null 0.0375780807984386 0.32681697
NSC 636087 Null 0.0375780807984386 0.17248678
NSC 639521 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-2-(phenylmethyl)-, hydrochloride 0.0375780807984386 0.21522991
NSC 665087 Null 0.0375780807984386 0.27420534
Total:70  Current:57    [First] [Prev] [Next] [Last]